Eli Lilly and CompanyLLY
▲ ポジティブ資本関連度
Eli Lilly beat EPS estimates with adjusted EPS up 33% to $8.38 on revenue of $23 billion, driven by GLP-1 portfolio.
銘柄への影響 8
Biotech & Genomic Medicine
Eli Lilly and Company
Merck & Company IncMRK
▲ ポジティブ資本関連度
Merck reported an adjusted loss but revenue rose 5.1% to $16.61 billion, beating EPS estimates.
Pfizer IncPFE
▲ ポジティブ資本関連度
Pfizer beat EPS estimates with adjusted EPS of $0.77 and raised full-year revenue guidance.
Vertex Pharmaceuticals IncVRTX
▼ ネガティブ資本関連度
Vertex Pharmaceuticals was the only firm to miss earnings estimates.
Health Care
STERIS plcSTE
▼ ネガティブ資本関連度
STERIS fell short on revenue, missing expectations.
Zoetis IncZTS
± 混在資本関連度
Zoetis fell short on revenue, but the article does not specify the impact on earnings or stock direction.
Cardinal Health IncCAH
言及
Critical Materials & Supply Chain
